The largest database of trusted experimental protocols

Ficoll hypaque density gradient

Manufactured by Cytiva
Sourced in Sweden, United States

Ficoll-Hypaque density gradient is a laboratory reagent used for the separation and isolation of cells, such as lymphocytes, from a heterogeneous cell population. It is a sterile, endotoxin-tested solution that creates a density gradient to facilitate the separation of different cell types based on their density.

Automatically generated - may contain errors

13 protocols using ficoll hypaque density gradient

1

Isolation of Porcine Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Pig blood was collected on 1.3 M citrate and mononuclear cells were isolated on Ficoll-Hypaque density gradient (Amersham Bioscience) and used fresh. Spleen cells were isolated by mechanical dissociation followed by filtration on successive 500 µm and 100 µm mesh-sized nylon filters and centrifugation on Ficoll-Hypaque density gradient. Spleen cells were step frozen in FCS + 10% dimethyl sulfoxide (DMSO) and stored in liquid nitrogen. Migrated cells from pig skin explants were obtained from 24 punch biopsies (8 mm), which were floated for 24 h on 10 ml RPMI 1640 medium + 10% FCS and antibiotics. Migrated cells were collected after loading on a 100 µm mesh-sized nylon filter and used fresh. Alveolar macrophages were collected as described, step frozen in FCS + 10% DMSO, and stored in liquid nitrogen (33 (link)). Broncho-alveolar lavage (BAL) was performed twice on isolated left lung with 250 ml PBS + 2 mM EDTA and the collected cells were step frozen and stored in liquid nitrogen.
+ Open protocol
+ Expand
2

Profiling Immune Cell Phenotypes and Metabolic Parameters in Aging Adults

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood was collected from adults (n=6, four females and 2 males) aged 64-67 years in 2015. Peripheral blood mononuclear cells were isolated using a Ficoll–Hypaque density gradient (Amersham Biosciences) and centrifugation. Viable cells were counted, adjusted to 2×106/100 μL in 80% fetal bovine serum and 20% dimethylsulfoxide (Sigma), and frozen stored until the phenotyping. In 2021, cells were thawed, checked for viability, and stained with monoclonal antibodies to the T cell phenotypes CD4 PerCP Cy5.5, CD8 APC Cy7, CD27 APC, CD45RA PE; B cell phenotypes CD19 PE, CD27 APC, IgD PE Cy5.5 (eBioscience), and ACE CD143 fluorescein isothiocyanate (R&D Systems). After 30 minutes of incubation with monoclonal antibodies in the dark at 4 °C, the cells were washed with phosphate-buffered saline and centrifuged. Living cells (based on forward and side scatter) were acquired in the BD FACSCanto II flow cytometry system using the DIVA software (Becton Dickinson).
For assessing metabolic parameters, the serum of studied individuals was previously isolated through centrifugation and frozen stored until use. Measurement of metabolic parameters was performed in the Laboratório Central–Hospital São Paulo, Federal University of São Paulo.
+ Open protocol
+ Expand
3

PBMC Isolation and Cryopreservation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peripheral blood mononuclear cells (PBMCs) were separated by Ficoll-Hypaque density gradient centrifugation (Amersham–Pharmacia, Uppsala, Sweden), washed three times with phosphate-buffered saline (GIBCO BRL) and cryopreserved in 90% heat-inactivated foetal calf serum (JRH Biosciences, Kansas, USA) and 10% DMSO (Sigma-Aldrich, Castle Hill, Australia).
+ Open protocol
+ Expand
4

Measuring Immunosuppressive Effects of MSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
To test the inhibitory effects of T1D-MSCs and C-MSCs on allogeneic lymphocyte proliferation, the carboxyfluorescein diacetate succinimidyl ester (CFSE; Invitrogen LifeTechnologies) dilution method was used. Peripheral blood mononuclear cells (PBMCs) obtained from healthy donors were separated by Ficoll-Hypaque density gradient (Amersham-Pharmacia), labeled with CFSE (10 μM, for 10 minutes at 37 °C), and resuspended in RPMI 1640 medium (Gibco) supplemented with 5 % human serum albumin (Vialebex® 200 mg/ml; LFB, Rio de Janeiro, Brazil). CFSE-labeled PBMCs were added to the wells containing previously adhered patient or control MSCs, in six different ratios (MSCs:PBMCs = 1:2, 1:5, 1:10, 1:20, 1:50, and 1:100) in the presence of 0.5 μg/ml phytohemagglutinin (PHA; Sigma‐Aldrich, St. Louis, MO, USA). The cocultures were incubated for 5 days at 37 °C with 5 % CO2. Subsequently, PBMCs were harvested, stained with anti‐CD3 antibody (BD, San Jose, CA, USA) and the dilution of CFSE in CD3+ T cells was analyzed by flow cytometry using FACSCalibur™ (BD) equipment.
+ Open protocol
+ Expand
5

Cryopreservation and Thawing of PBMC

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMC were isolated by standard Ficoll-Hypaque density gradient centrifugation (Amersham Pharmacia) and cryopreserved in 90% heat-activated fetal calf serum (FCS, Invitrogen) plus 10% DMSO and stored in liquid nitrogen until needed. Cryopreserved PBMC were thawed and rested in R10 [RPMI 1640 containing 10% heat-inactivated FCS (Sigma) and 50 U/ml of penicillin-streptomycin] at 37°C and 5% CO2 for 8 hours prior to antigen stimulation.
+ Open protocol
+ Expand
6

Isolation and Sorting of CD4+ T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peripheral blood mononuclear cells (PBMC) were isolated by Ficoll‐Hypaque density gradient (Amersham Pharmacia Biotech) from peripheral blood of healthy volunteers, after informed consent with the approval of the Ethics Committee of Lisbon Academic Medical Centre.
CD4 T cells were negatively selected using the EasySep Human CD4+ T‐cell enrichment kit (StemCell Technologies), stained for CD3, CD4, CD25, and CD127, and subsequently sorted into Treg and Tcon cells using a FACSAria flow cytometer (BD Biosciences).
+ Open protocol
+ Expand
7

Autologous CIK Cell Preparation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Autologous CIK cells were prepared as previously described [14 (link)]. Briefly, peripheral blood mononuclear cells (PBMCs) from participants were obtained from whole blood by centrifugation over Ficoll-Hypaque density gradient (Ficoll-Paque Plus; Amersham Biosciences). The PBMCs (2 × 106 cells/mL) were incubated in fresh RMPI-1640 medium (HyClone, USA) containing 10% serum and 1000 U/mL recombinant human gamma-interferon (IFN-γ, PeproTech, USA). After incubation for 24 h, anti-CD3 antibody (100 ng/mL, BioLegend, USA), recombinant human interleukin- (IL-) 1α (100 U/mL, PeproTech, USA), and recombinant human IL-2 (1000 U/mL, PeproTech, USA) were added to the medium. Cells were incubated and fed every 2 days in fresh complete medium supplemented with rhIL-2 (1000 U/mL) and maintained at a density of 2 × 106 cells/mL.
+ Open protocol
+ Expand
8

Cell Lines and PBMC Isolation for Cytotoxicity Studies

Check if the same lab product or an alternative is used in the 5 most similar protocols
Colon cancer cell lines HCT116 (p53+/+), HCT116 (p53−/−) and HT29 (p53mt), breast cancer cell lines MDA-MB-231 (p53mt) and MCF-7 (p53+/+) were obtained from NCCS, India. Blood collected from healthy human volunteers with informed consent (Institutional Review Board 1382) was centrifuged over Ficoll-Hypaque density gradient (Amersham Pharmacia, Uppsala, Sweden) to obtain total peripheral blood mononuclear cells (PBMC)48 (link). Cells were routinely maintained in complete DMEM/RPMI 1640 at 37 °C in a humidified incubator containing 5% CO2. Cells were allowed to reach confluency before use. Dose-dependent and time-dependent cell death experiments were performed using Trypan blue-exclusion test49 (link). All experiments were performed in accordance with approved guidelines and regulations of the Helsinki Declaration (http://www.wma.net/en/30publications/10policies/b3/index.html). All experimental protocols were approved by informed consent (IRB-1382), Human Ethics Committee, Bose Institute (Approval No: BIHEC/2010-11/2).
+ Open protocol
+ Expand
9

Isolation and Culture of K562 Cells and Primary CML CD34+ Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human myelogenous leukaemia cell line K562 were obtained from America Type Culture Collection (ATCC, Manassas, VA, USA) and cultured in RPMI-1640 (Sigma, St. Louis, MO, USA) medium containing 10% heat-inactivated fetal calf serum (FCS, Hyclone, Logan, UT, USA), 100 unit/ml penicillin and 100 μg/ml streptomycin in a humidified 5% CO2 atmosphere at 37°C.
The bone marrow (BM) samples were obtained from healthy donor or CML patients undergoing diagnostic procedures at Peking university first hospital. Written informed consent was obtained from each healthy donor and CML patient. All the procedures were approved by the Ethics Committee of Beijing Institute of Radiation Medicine. Mononuclear cells were isolated from heparinized samples by centrifugation through a Ficoll-Hypaque density gradient (Amersham Biosciences, Piscataway, NJ, USA). Then, CD34+ cells were isolated by using human CD34 positive selection kit (Stem Cell Technology, Vancouver BC, Canada).
+ Open protocol
+ Expand
10

Characterizing Immune Profiles in HIV Cohorts

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood samples were collected at enrollment on tubes with EDTA and centrifuged to separate plasma, which was stored at −80 °C until use. Peripheral blood mononuclear cells (PBMCs) were isolated by Ficoll-Hypaque density gradient centrifugation (Amersham, Sweden) and cryopreserved. For those PHI patients that remained ART naïve, additional samples were obtained at a median of 330 days p.i (see Table 1). For Chronics, ECs and PHIs, plasma VL (branched-DNA, Versant HIV-1 RNA 3.0 assay; Siemens Healthcare) and CD4/CD8 counts (flow cytometry double platform, BD FACSCanto; BD Biosciences) were determined.
Subsequent functional assays were performed, according to sample availability, using only thawed cells that showed >95% viability after overnight rest in complete RPMI medium [RPMI-1640 (Sigma-Aldrich, USA) supplemented with 10% fetal bovine serum (Gibco, USA), 2 mM L-glutamine (Sigma-Aldrich, USA), 100 U/ml penicillin (Sigma-Aldrich, USA), 100 mg/ml streptomycin (Sigma-Aldrich, USA), and 10 mM HEPES (Gibco, USA)].
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!